
    
      The screening period was 28 days. The classification of CNV will be determined by Fundus
      Fluorescein Angiography ( FFA ) at the study centers. Subjects will receive intravitreal
      injections of TAB014 Monoclonal Antibody Injection in one eye ( the study eye ). Subjects
      will only receive single intravitreal dose.
    
  